These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19888963)

  • 1. Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis.
    Campia I; Lussiana C; Pescarmona G; Ghigo D; Bosia A; Riganti C
    Br J Pharmacol; 2009 Dec; 158(7):1777-86. PubMed ID: 19888963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells.
    Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K
    Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin on the metabolism of polyunsaturated fatty acids and on glycerolipid, cholesterol, and de novo lipid synthesis in THP-1 cells.
    Risé P; Colombo C; Galli C
    J Lipid Res; 1997 Jul; 38(7):1299-307. PubMed ID: 9254057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of COX-2 expression by statins in human monocytic cells.
    Habib A; Shamseddeen I; Nasrallah MS; Antoun TA; Nemer G; Bertoglio J; Badreddine R; Badr KF
    FASEB J; 2007 Jun; 21(8):1665-74. PubMed ID: 17317725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
    Fernández-Hernando C; Suárez Y; Lasunción MA
    Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
    Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
    J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.
    Li HY; Appelbaum FR; Willman CL; Zager RA; Banker DE
    Blood; 2003 May; 101(9):3628-34. PubMed ID: 12506040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of hepatocyte pretreatment with coenzyme Q10 against statin toxicity.
    Eghbal MA; Abdoli N; Azarmi Y
    Arh Hig Rada Toksikol; 2014 Mar; 65(1):101-8. PubMed ID: 24535294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.
    Haney SL; Varney ML; Chhonker Y; Talmon G; Smith LM; Murry DJ; Holstein SA
    Pharmacol Res; 2021 May; 167():105528. PubMed ID: 33667685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
    Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
    J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevastatin suppresses lipopolysaccharide-induced Rac activation in the human monocyte cell line THP-1.
    Patel TR; Corbett SA
    Surgery; 2003 Aug; 134(2):306-11. PubMed ID: 12947334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting geranylgeranylation increases neurite branching and differentially activates cofilin in cell bodies and growth cones.
    Samuel F; Reddy J; Kaimal R; Segovia V; Mo H; Hynds DL
    Mol Neurobiol; 2014 Aug; 50(1):49-59. PubMed ID: 24515839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells.
    Maeda A; Yano T; Itoh Y; Kakumori M; Kubota T; Egashira N; Oishi R
    Atherosclerosis; 2010 Jan; 208(1):112-8. PubMed ID: 19683239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
    Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
    Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
    Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
    J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.